Universal Corporation logo

Universal Corporation (UVV)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
53. 08
-1.3
-2.3906%
Pre Market
$
54. 48
+1.4 +2.6375%
1.36B Market Cap
- P/E Ratio
3.28% Div Yield
249,207 Volume
- Eps
$ 54.38
Previous Close
Add Transaction
Day Range
52.78 54.32
Year Range
49.19 61.67
Want to track UVV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Universal Health Services beats fourth-quarter profit estimates on higher hospital admissions

Universal Health Services beats fourth-quarter profit estimates on higher hospital admissions

Hospital operator Universal Health Services beat fourth-quarter profit estimates on Wednesday, driven by robust demand for medical care that required hospital stays.

Reuters | 1 year ago
Universal Health to Report Q4 Earnings: What Do the Estimates Say?

Universal Health to Report Q4 Earnings: What Do the Estimates Say?

UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.

Zacks | 1 year ago
Universal Display Q4 Earnings Beat on Higher Material Sales

Universal Display Q4 Earnings Beat on Higher Material Sales

OLED reports top-line growth year over year, driven by growing traction in the IT, automotive, smartphone and TV end markets.

Zacks | 1 year ago
Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. Fortunately, they recently enrolled 5,000 subjects in its Phase 2b trial to assess CD388's safety and efficacy. CD388 inhibits viral replication and activates the immune response, and its mechanism of action actually received the FDA's Fast Track designation.

Seekingalpha | 1 year ago
Universal Health Services: A Quality GARP Company With Significant Upside

Universal Health Services: A Quality GARP Company With Significant Upside

Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in adjusted diluted EPS and improved EBITDA margins, underscores its resilience and efficiency. With COVID disruptions over, UHS is poised for 6%-7% long-term growth, supported by robust performance in both acute and behavioral health segments.

Seekingalpha | 1 year ago
Universal Technical Q1 Earnings Beat Estimates, FY25 View Up

Universal Technical Q1 Earnings Beat Estimates, FY25 View Up

UTI's first-quarter fiscal 2025 results indicate growth in new student starts and average full-time active students at UTI and Concorde.

Zacks | 1 year ago
Universal Technical to Report Q1 Earnings: Here's What to Expect

Universal Technical to Report Q1 Earnings: Here's What to Expect

UTI's first-quarter fiscal 2025 results are likely to reflect growth in average full-time active students. Dive in to get a clear picture ahead of earnings.

Zacks | 1 year ago
Universal, Spotify ink multi-year deal

Universal, Spotify ink multi-year deal

Universal Music Group, the world's largest music company, and streaming behemoth Spotify on Sunday announced a multi-year direct deal that will affect both recording and publishing royalty rates.

Techxplore | 1 year ago
Spotify, Universal Music Group Strike Multi-Year Deal

Spotify, Universal Music Group Strike Multi-Year Deal

Spotify and Universal Music Group have struck a new multi-year agreement for recorded music and music publishing “focused on growth, innovation and the advancement of artists' and songwriters' success.

Deadline | 1 year ago
Universal Music Group and Spotify strike new agreement

Universal Music Group and Spotify strike new agreement

Universal Music Group (UMG) , the world's biggest music label, and Swedish streaming giant Spotify have reached a new multi-year agreement for recorded music and music publishing, they said on Sunday.

Reuters | 1 year ago
Universal's 'Wicked: For Good' creates a unique marketing challenge

Universal's 'Wicked: For Good' creates a unique marketing challenge

Universal garnered 10 Academy Award nominations for "Wicked," a boon for marketing efforts for the second part of the duology, "Wicked: For Good." The film already has pent-up audience demand following a record-breaking box office run both domestically and globally.

Cnbc | 1 year ago
Universal Display: Good Returns, But Not As Good As The S&P500 - Updating For 2025E

Universal Display: Good Returns, But Not As Good As The S&P500 - Updating For 2025E

Universal Display Corporation remains a fundamentally attractive investment, with a market-leading position in OLED technology and strong partnerships with LG and Samsung. Despite a recent decline in valuation and lowered revenue forecasts, OLED's long-term growth prospects remain solid, driven by increasing adoption and cost efficiencies. The company's current valuation offers a potential upside of 18-22% annualized, making it a compelling "Buy" at around $168/share.

Seekingalpha | 1 year ago
Loading...
Load More